0001104659-23-079724.txt : 20230710 0001104659-23-079724.hdr.sgml : 20230710 20230710175157 ACCESSION NUMBER: 0001104659-23-079724 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230706 FILED AS OF DATE: 20230710 DATE AS OF CHANGE: 20230710 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOGAN H MICHAEL III CENTRAL INDEX KEY: 0001105963 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 231080739 MAIL ADDRESS: STREET 1: C/O 3D SYSTEMS STREET 2: 26081 AVENUE HALL CITY: VALENCIA STATE: CA ZIP: 91355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25-28 NORTH WALL QUAY CITY: DUBLIN STATE: L2 ZIP: D01 H104 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 414 COMMERCE DRIVE STREET 2: STE 120 CITY: FORT WASHINGTON STATE: PA ZIP: 19034 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 3 1 tm2320988-2_3seq1.xml OWNERSHIP DOCUMENT X0206 3 2023-07-06 1 0001641640 Nabriva Therapeutics plc NBRV 0001105963 HOGAN H MICHAEL III 414 COMMERCE DRIVE SUITE 120 WASHINGTON PA 19034 0 1 0 0 Chief Executive Officer /s/ H. Michael Hogan III 2023-07-10